Show items per page
Elements: 106
Page 1 on 6
 TitleAuthors / EditorsDate
add to browser selection
Pheochromocytoma presented by Takotsubo, unmasked by accumulation of paroxetine, in a cytochrome poor metabolizer patient: A case report Bettini, Luca; Serratrice, Jacques; Jornayvaz, François 2022
add to browser selection
Diabétologie Gariani, Karim; Jornayvaz, François 2021
add to browser selection
Is routine measurement of the serum C-reactive protein level helpful during antibiotic therapy for diabetic foot infection? Pham, Truong-Thanh; Wetzel, Oliver; Gariani, Karim; Kressmann, Benjamin; ... Uçkay, İlker 2021
add to browser selection
Pathophysiology of NASH in endocrine diseases Gariani, Karim; Jornayvaz, François 2021
add to browser selection
Ether lipids, sphingolipids and toxic 1-deoxyceramides as hallmarks for lean and obese type 2 diabetic patients Hannich, Joerg Thomas; Loizides-Mangold, Ursula Elfriede; Sinturel, Flore; Harayama, Takeshi; ... Dibner, Charna 2021
add to browser selection
Diabète: et si on se mettait à la place du patient? Wojtusciszyn, Anne; Jornayvaz, François 2020
add to browser selection
Thirteen-year trends in the prevalence of diabetes according to socioeconomic condition and cardiovascular risk factors in a swiss population de Mestral, Carlos; Stringhini, Silvia; Guessous, Idris; Jornayvaz, François 2020
add to browser selection
Effectiveness and safety of insulin glargine 300 U/mL in insulin-naïve patients with type 2 diabetes after failure of oral therapy in a real-world setting Pfohl, Martin; Jornayvaz, François; Fritsche, Andreas; Pscherer, Stefan; ... Seufert, Jochen 2020
add to browser selection
Real-World Effectiveness of Insulin Glargine 300 Initiation in Switzerland Thomann, Robert; Zechmann, Stefan; Alexander-David, Nicola; Jornayvaz, François 2020
add to browser selection
Three versus six weeks of antibiotic therapy for diabetic foot osteomyelitis: A prospective, randomized, non-inferiority pilot trial Gariani, Karim; Pham, Truong-Thanh; Kressmann, Benjamin; Jornayvaz, François; ... Uckay, Ilker 2020
add to browser selection
La NASH: une complication moins connue mais importante du diabète Gariani, Karim; Jornayvaz, François 2020
add to browser selection
Quelle place pour les inhibiteurs de la DPP-4 en 2020? Caironi, Verdiana; Jornayvaz, François; Gariani, Karim 2020
add to browser selection
Diabète après transplantation rénale : mise au point Gariani, Karim; Jornayvaz, François; Hadaya, Karine 2020
add to browser selection
Diabétologie Jornayvaz, François; Gariani, Karim 2020
add to browser selection
The GLP-1R agonist liraglutide limits hepatic lipotoxicity and inflammatory response in mice fed a methionine-choline deficient diet Somm, Emmanuel; Montandon, Sophie Anne; Loizides-Mangold, Ursula Elfriede; Gaia, Nadia; ... Jornayvaz, François 2020
add to browser selection
Extremely high-dose insulin requirement in a diabetic patient with COVID-19: a case report Jornayvaz, François; Assouline, Benjamin; Pugin, Jérôme; Gariani, Karim 2020
add to browser selection
Ulcère du pied chez un patient avec un diabète : quelle prise en charge médico-chirurgicale ? Mohamad, Morad; Pham, Truong-Thanh; Jornayvaz, François; Pignel, Rodrigue; ... Suva, Domizio 2020
add to browser selection
Salivary cortisol is not associated with incident insulin resistance or type 2 diabetes mellitus Gariani, Karim; Marques-Vidal, Pedro; Waeber, Gérard; Vollenweider, Peter; Jornayvaz, François 2019
add to browser selection
Nonalcoholic fatty liver disease burden Goossens, Nicolas; Bellentani, Stefano; Cerny, Andreas; Dufour, Jean-François; ... Semela, David 2019
add to browser selection
Multi-technique comparison of atherogenic and MCD NASH models highlights changes in sphingolipid metabolism Montandon, Sophie; Somm, Emmanuel; Loizides-Mangold, Ursula; De Vito, Claudio; ... Jornayvaz, François 2019
<< previous | 1 | 2 | 3 | 4 | 5 | 6 |